Healthcare News

The PIONEER program marks a key step toward potential first-in-class neuroprotection for optic neuritis and other neurological diseases, supported by positive Acuity Phase 2 data, FDA Breakthrough...

PIONEER-áætlunin markar mikilvægt skref í átt að hugsanlega fyrstu taugaverndandi meðferð sinnar tegundar við sjóntaugabólgu og öðrum taugasjúkdómum, studd af jákvæðum gögnum úr fasa 2...

ZUG, Switzerland, August 24th, 2026 -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet...

TME Pharma enters final evaluation phase with two potential partners for licensing lead asset NOX-A12 to support Phase 2 glioblastoma development

TME Pharma entre en phase finale avec deux partenaires pour la licence du NOX-A12 et le développement de Phase 2 dans le glioblastome.

Phonak today launched EON, its next-generation hearing aid platform.

Orum receives FDA clearance for ORM-1153, advancing its novel CD123-GSPT1 degrader-antibody conjugate toward Phase 1 in hematologic malignancies.

Integrity Urgent Care opens in Murphy, Texas, expanding seven-day walk-in and virtual care for families, schools and employers across Collin County.

SAN CARLOS, Calif., Aug. 21, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and...

FREMONT, Calif., Aug. 21, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences,” “Cytek,” or the “Company”) (Nasdaq: CTKB), a leading cell analysis solutions company, today announced...